Home

Ascendis Pharma A/S - American Depositary Shares (ASND)

199.16
+4.89 (2.52%)
NASDAQ · Last Trade: Sep 2nd, 10:44 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Technical Strength and High-Growth Momentumchartmill.com
Ascendis Pharma (ASND) excels in both technical & fundamental momentum, meeting Minervini's Trend Template criteria for high-growth stocks poised for potential outperformance.
Via Chartmill · September 1, 2025
How Do Investors Really Feel About Ascendis Pharma?benzinga.com
Via Benzinga · August 28, 2025
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · August 19, 2025
Ascendis (ASND) Q2 2025 Earnings Call Transcriptfool.com
Via The Motley Fool · August 7, 2025
Earnings Scheduled For August 7, 2025benzinga.com
Via Benzinga · August 7, 2025
What's Driving the Market Sentiment Around Ascendis Pharma?benzinga.com
Via Benzinga · August 6, 2025
Peering Into Ascendis Pharma's Recent Short Interestbenzinga.com
Via Benzinga · July 3, 2025
Is Ascendis Pharma Gaining or Losing Market Support?benzinga.com
Via Benzinga · June 3, 2025
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · May 29, 2025
Earnings Scheduled For May 1, 2025benzinga.com
Via Benzinga · May 1, 2025
What's Driving the Market Sentiment Around Ascendis Pharma?benzinga.com
Via Benzinga · August 4, 2025
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · July 28, 2025
Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · July 22, 2025
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · July 7, 2025
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · June 12, 2025
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · May 21, 2025
A Glimpse of Ascendis Pharma's Earnings Potentialbenzinga.com
Via Benzinga · April 30, 2025
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 15 Yearsbenzinga.com
Via Benzinga · May 6, 2025
This Twilio Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Mondaybenzinga.com
Via Benzinga · May 5, 2025
Why ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) could fit Mark Minervini’s high-growth criteriachartmill.com
A fundamental and technical analysis of (NASDAQ:ASND): Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) suited for high growth investing?
Via Chartmill · April 28, 2025
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · April 15, 2025
Does ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) show the characteristics of a Minervini super stock?chartmill.com
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND).
Via Chartmill · April 4, 2025
Looking Into Ascendis Pharma's Recent Short Interestbenzinga.com
Via Benzinga · March 26, 2025
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · March 25, 2025
Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) a Minervini-style stock?chartmill.com
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND).
Via Chartmill · March 14, 2025